WHO likely to decide on Covaxin EUL today as Bharat Biotech submits additional data

The Technical Advisory Group of WHO will conduct a EUL risk-benefit assessment meeting for the global use of Bharat Biotech's COVID jab, Covaxin, today.

Related Keywords

Philippines ,Iran ,China ,Mauritius ,Mexico ,India ,Estonia ,Mumbai ,Maharashtra ,Hyderabad ,Andhra Pradesh ,Zimbabwe ,Nepal ,Geneva ,Genè ,Switzerland ,Paraguay ,Guyana ,Ankleshwar ,Gujarat ,Bengaluru ,Karnataka ,Chinese ,Bharat ,Mariangela Simao ,National Institute Of Virology ,Bharat Immunologicals Biologicals Limited In Bulandshahr ,Indian Council Of Medical Research ,Health Products ,World Health Organisation ,Indian Immunologicals ,Haffkine Biopharmaceutical Corporation Ltd ,Advisory Group ,Bharat Biotech ,Emergency Use Listing ,Health Organisation ,Whole Virion Inactivated Coronavirus Vaccine ,Indian Council ,Medical Research ,National Institute ,Indian Immunologicals Limited ,Bharat Immunologicals Biologicals Limited ,Covaxin ,